Livial R: clinical and metabolic profile.

Abstract

Hormone replacement therapy is becoming increasingly an important area. All current therapies have safety problems or acceptance by patients. In particular, regular vaginal bleeding, commonly in postmenopausal women it is unacceptable. Livial a steroid gonadomimético, effectively treats postmenopausal symptoms, and prevents postmenopausal bone loss, without stimulating the endometrium, so it does not cause bleeding in women who are in this stage. Livial seems to have little significant side effects, can exert even more beneficial effect on the cardiovascular system and serum lipid profile.